Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Darbosis 25mcg Injection

Prescription Icon
Prescription Required

Marketer

Micro Labs Ltd

Salt Composition

Darbepoetin alfa (25mcg)

Overview Darbosis 25mcg Injection

Erythropoietin alfa (25mcg injection) treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. This medication requires careful administration due to potential serious adverse reactions; expert medical supervision is essential. Strict adherence to physician instructions is paramount. Administration occurs under healthcare professional guidance. Frequent side effects may include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension, such as intense headache, visual disturbances, nausea, vomiting, or convulsions, immediately. Regular blood tests monitoring electrolyte levels (potassium), hemoglobin, and blood cell counts will be conducted by your physician. Discontinue use and consult your doctor if shortness of breath or a skin rash develops. Prior to treatment, inform your physician of any pre-existing heart conditions, hypertension, history of seizures or stroke. Consult your doctor regarding pregnancy, breastfeeding, or pregnancy plans to ensure safety.

Primary Ingredients of Darbosis 25mcg Injection

No text provided. Please provide the text you want me to rephrase.

Uses of Darbosis 25mcg Injection

Managing anemia in patients with chronic kidney disease | Addressing anemia resulting from cancer chemotherapy

Major Benefits of Darbosis 25mcg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Darbosis 25mcg Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Darbosis 25mcg Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Darbosis 25mcg Injection works:

Darbosis 25mcg Injection is a medication that boosts red blood cell production (an erythropoiesis-stimulating agent or ESA). This effect is achieved by prompting the bone marrow — the blood cell-forming tissue within bones — to increase red blood cell output.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Darbosis 25mcg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Darbosis 25mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Darbosis 25mcg Injection while breastfeeding may pose a risk. Available human data indicate potential drug transfer to breast milk, potentially harming the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Darbosis 25mcg Injection.

KidneyKidneySAFE IF PRESCRIBED

Darbosis 25mcg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverCAUTION

Patients with liver impairment should use Darbosis 25mcg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Darbosis 25mcg Injection :

For Darbosis 25mcg Injection, administer the missed dose promptly if remembered. However, if the next scheduled dose is imminent, omit the forgotten dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Darbosis 25mcg Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Type of Therapy KINSHIP
Actions Erythropoietin-stimulating drug

FAQs on Darbosis 25mcg Injection

Within 2 to 6 weeks of beginning Darbosis 25mcg injections, you should see a rise in your red blood cell count (hemoglobin levels). Consult your doctor with any other questions.
Darbosis 25mcg Injection requires careful administration due to the potential for serious adverse reactions, including fatalities. Expert medical supervision by a physician experienced with Darbosis 25mcg Injection therapy is essential. Adhere strictly to all prescribed instructions.
Darbosis 25mcg Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; correct these deficiencies before treatment. Other factors affecting treatment response include bleeding, infections, inflammation, and bone marrow fibrosis. Consult your doctor for further guidance.
Darbosis 25mcg Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults. Consult your physician if you have any concerns.
Darbosis 25mcg Injection can influence blood pressure. Blood pressure monitoring is crucial during initial treatment. Patients with hypertension should manage their blood pressure appropriately; the injection may be discontinued if blood pressure remains uncontrolled.
Darbosis 25mcg Injection is contraindicated for individuals without a doctor's prescription. It should also be avoided by patients with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by Darbosis 25mcg Injection or similar erythropoietin medications, or a history of serious allergic reactions to this drug.
Darbosis 25mcg Injection
1,296
MRP 1,500
13% off